Cardiovascular Diseases, Dementia, Diabetes, Frailty, Hypertension
Conditions
Keywords
Mediterranean Diet, MIND Diet, Healthy Aging
Brief summary
This study aims to develop and validate a tool for immediate nutrition assessment and to test its user feasibility in routine clinical practice for health promotion.
Detailed description
Small changes in diet have been shown to have an important impact on health and the risk of age-related chronic diseases, such as cardiovascular disease, diabetes, frailty and dementia. However, this knowledge has not yet been implemented into routine clinical practice, because practical tools that allow a comprehensive nutrition assessment in the clinical care setting are missing. In addition, doctors are generally not educated in giving nutritional advice to patients. In this pilot project, we aim to push forward and enable the potential of nutrition as a core primary prevention strategy for people at risk of developing chronic diseases. This will be achieved by using, as a stepping stone, the electronic 216-food-item food frequency questionnaire which was developed for the European DO-HEALTH study and was tested in over 2000 adults. The investigators want to extend this tool to not only capture the personal dietary intake, but also to produce an immediate report, comparing the personal diet to the Mediterranean and MIND diet patterns and providing a patient's intake of protein and other nutrients. The report will additionally indicate the patient's diet-related, personalized risks of cardio-vascular disease, diabetes, frailty and cognitive decline, and recommend dietary changes to reduce these risks.
Interventions
DEVICEeNutrition Optimizer
The eNutrition optimizer is based on the electronic food frequency questionnaire (FFQ) used in the multicentre randomized controlled trail DO-HEALTH \[56\] developed by the CAM. The FFQ is split up in sections of 33 food groups and contains 216 items. It asks the user on the relative frequency of consumption of the different foods showing a picture of the food in the portion size of interest. Within the eNutrition Optimizer, the FFQ will be extended to create an output of the user's adherence to the Mediterranean diet, the MIND diet and the adherence with the current dietary recommendations for micro- and macronutrients provided by the Swiss Society for Nutrition and the DACH-references, compare it to the DO-HEALTH population and give recommendations on how to improve the score.
Sponsors
Heike Bischoff-Ferrari
Study design
Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE
Intervention model description
Pilot study (exploratory case-crossover study) for user feasibility and validation of the eNutrition Optimizer
Eligibility
Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
1. Stable inpatients from the Department of heart surgery, or Center for senior trauma patient at the university hospital Zurich (inpatient group) 2. Ambulatory volunteers who can visit the center for aging and mobility (CAM) independently (outpatients group) 3. ≥50 years
Exclusion criteria
1. If already involved in another ongoing interventional clinical trial, except an interaction with this intervention can be excluded 2. People with an impaired short-term memory (MMSE \<24) 3. Patients following a specific diet recommended by a medical professional, due to diseases such as diabetes, chronic diseases of the gastrointestinal tract, severe kidney disease, or patients allergic to the main components of the Mediterranean diet/MINDdiet (olive oil, nuts) 4. Outpatients: HbA1C ≥6.5% Inpatients: HbA1C ≥6.5% or diagnosed diabetes mellitus if HbA1C is not available in KISIM 5. BMI \> 30 kg/m2 6. Individuals per se not willing to change diet 7. Instable clinical conditions (e.g. acute infection) at enrolment 8. Patients with active cancer (except non-melanoma skin cancer) or current cancer treatment or any other advanced severe disease 9. Living in a nursing home and/or receiving prepared meals (i.e. usually not eating home cooked meals) 10. Inability to read and or speak German necessary to understand the instructions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Perception questionnaire using system usability scale | Baseline | Feasibility Study (in- and outpatient group) Scale from 1 to 5, indicating 1 not true, 5 very true |
| Subjective effectiveness questionnaire of eNutrition Optimizer | month 3 to 6 | Feasibility Study (in- and outpatient group) Scale from 1 to 5, indicating 1 not true, 5 very true |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| blood marker HDL cholesterol (mmol/l) | 6 months | Validation Study (outpatient group) |
| blood marker Triglycerides (mmol/l) | 6 months | Validation Study (outpatient group) |
| blood marker HbA1C (%) | 6 months | Validation Study (outpatient group) |
| blood marker Fasting glucose (mmol/l) | 6 months | Validation Study (outpatient group) |
| blood marker Vitamin B12 (ng/l) | 6 months | Validation Study (outpatient group) |
| blood marker Folate (µg/l) | 6 months | Validation Study (outpatient group) |
| blood marker Iron (µmol/l) | 6 months | Validation Study (outpatient group) |
| blood marker Transferrin (µmol/l) | 6 months | Validation Study (outpatient group) |
| 24h diet recalls | month 4 to 6 | Validation Study (outpatient group) |
| blood marker Ferritin (µg/l) | 6 months | Validation Study (outpatient group) |
| blood marker high sensitive-CRP (mg/l) | 6 months | Validation Study (outpatient group) |
| blood marker Interleukin-6 (pg/ml) | 6 months | Validation Study (outpatient group) |
| Dietary patterns assessed with the eNutrition Optimizer (based on a food frequency questionnaire), MIND diet score ranging from 0 to 15 with 0=worst, 15=best ; Med Diet score ranging from 0 to 55 with 0=worst, 15=best | 6 months | Change in diet (outpatient group) |
| BMI | 6 months | Change in diet (outpatient group) and safety (outpatient group) |
| waist-to-hip ratio | 6 months | Change in diet (outpatient group) and safety (outpatient group) |
| systolic and diastolic blood pressure | 6 months | Change in diet (outpatient group) |
| blood marker Soluble transferrin receptor (mg/l) | 6 months | Validation Study (outpatient group) |
| blood marker Non-HDL cholesterol (mmol/l) | 6 months | Validation Study (outpatient group) |
Countries
Switzerland
Outcome results
None listed